Viewing data from:

VELIVET

ANDA

DESOGESTREL; ETHINYL ESTRADIOL | A076455 | DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: CYCLESSA(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Velivet (2023)

Total Spending

$35K

Total Claims

803

Beneficiaries

147

Avg Cost/Unit

$0.81

Spending Trend

$44K(2019)→$47K(2020)→$42K(2021)→$38K(2022)→$35K(2023)

YoY Change:+2.3%

5yr CAGR:+0.7%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Feb 24, 2004

No patent or exclusivity listings for this strength.